| 标题： | 长三角基于药品快速评价的新型抗肿瘤药临时采购专家共识 |
| title： | Expert Consensus on Interim Procurement of Novel Antineoplastic Drugs Based on Rapid Drug Evaluation in Yangtze River Delta |
| 版本： | 原创版 |
| version： | Original |
| 分类： | 专家共识 |
| classification： | Experts consensus |
| 领域： | 其他 |
| field： | Others |
| 国家和地区： | 中国 |
| Country and region： | China |
| 指南使用者： | 本共识适用于开展药品临时采购工作的各级医疗机构。 |
| Guide users： | This consensus applies to medical institutions at all levels that carry out temporary procurement of antineoplastic drugs. |
| 证据分级方法： | 德尔菲法 |
| Evidence grading method： | Delphi method |
| 制定单位： | 《长三角基于药品快速评价的新型抗肿瘤药临时采购专家共识》专家组 |
| Formulating unit： | Chinese Expert Consensus Panel on Interim Procurement of Novel Antineoplastic Drugs Based on Rapid Drug Evaluation in Yangtze River Delta |
| 注册时间： | 2023-03-15 |
| Registration time： | |
| 注册编号： | PREPARE-2023CN166 |
| Registration number： | |
| 指南制订的目的： | 随着新药上市速度的不断加快，新型抗肿瘤药品的临时采购需求日益增高，为解决新型抗肿瘤药物临时采购过程中存在的问题，特制定本共识，以期为各级医疗机构新型抗肿瘤药物的临时采购提供参考依据。 |
| Purpose of the guideline： | In order to solve the problems in the process of temporary procurement of new antitumor drugs, this consensus is formulated to provide reference basis for the temporary procurement of new antitumor drugs for medical institutions at all levels. |
